Literature DB >> 5770524

Rifampicin--a new antitrachoma drug.

Y Becker, Z Zakay-Rones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5770524     DOI: 10.1038/222851a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin.

Authors:  J D Treharne; P J Yearsley; R C Ballard
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

3.  Developmental regulation of tandem promoters for the major outer membrane protein gene of Chlamydia trachomatis.

Authors:  R S Stephens; E A Wagar; U Edman
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

Review 4.  The chlamydia: molecular biology of procaryotic obligate parasites of eucaryocytes.

Authors:  Y Becker
Journal:  Microbiol Rev       Date:  1978-06

5.  Treatment of acute gonorrhoea with a single oral dose of rifampicin.

Authors:  J Panduro
Journal:  Br J Vener Dis       Date:  1971-12

6.  Rifampicin and viruses.

Authors: 
Journal:  Br Med J       Date:  1969-06-07

Review 7.  Actions of the rifamycins.

Authors:  W Wehrli; M Staehelin
Journal:  Bacteriol Rev       Date:  1971-09

Review 8.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

9.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Synthesis of trachoma agent proteins in emetine-treated cells.

Authors:  Y Becker; Y Asher
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.